95 related articles for article (PubMed ID: 22771726)
1. Receptor for advanced glycation end products (RAGE) and glyoxalase I gene polymorphisms in pathological pregnancy.
Germanová A; Muravská A; Jáchymová M; Hájek Z; Koucký M; Mestek O; Zima T; Kalousová M
Clin Biochem; 2012 Nov; 45(16-17):1409-14. PubMed ID: 22771726
[TBL] [Abstract][Full Text] [Related]
2. Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer.
Krechler T; Jáchymová M; Mestek O; Zák A; Zima T; Kalousová M
Clin Biochem; 2010 Jul; 43(10-11):882-6. PubMed ID: 20398646
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of the receptor for advanced glycation end products and glyoxalase I and long-term outcome in patients with breast cancer.
Tesarova P; Zima T; Kubena AA; Kalousova M
Tumour Biol; 2017 Jul; 39(7):1010428317702902. PubMed ID: 28695773
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of the receptor for advanced glycation end-products and glyoxalase I in patients with renal cancer.
Chocholatý M; Jáchymová M; Schmidt M; Havlová K; Křepelová A; Zima T; Babjuk M; Kalousová M
Tumour Biol; 2015 Mar; 36(3):2121-6. PubMed ID: 25407489
[TBL] [Abstract][Full Text] [Related]
5. Soluble receptor for advanced glycation end products in physiological and pathological pregnancy.
Germanová A; Koucký M; Hájek Z; Parízek A; Zima T; Kalousová M
Clin Biochem; 2010 Mar; 43(4-5):442-6. PubMed ID: 19909734
[TBL] [Abstract][Full Text] [Related]
6. RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study.
Wang P; Huang R; Lu S; Xia W; Cai R; Sun H; Wang S
PLoS One; 2016; 11(1):e0145521. PubMed ID: 26745632
[TBL] [Abstract][Full Text] [Related]
7. The effects of Advanced Glycation End Products (RAGE)-374T/A and Gly82Ser variants and soluble-RAGE levels to obesity in children.
Kucukhuseyin O; Ozgen T; Karagedik EH; Cesur Y; Yilmaz Aydogan H; Yaylim I; Ergen HA
Cell Mol Biol (Noisy-le-grand); 2016 Apr; 62(5):9-14. PubMed ID: 27188863
[TBL] [Abstract][Full Text] [Related]
8. Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study.
Hájek Z; Germanová A; Koucký M; Zima T; Kopecký P; Vítkova M; Parízek A; Kalousová M
J Perinat Med; 2008; 36(5):399-404. PubMed ID: 18771410
[TBL] [Abstract][Full Text] [Related]
9. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.
Gaens KH; Ferreira I; van der Kallen CJ; van Greevenbroek MM; Blaak EE; Feskens EJ; Dekker JM; Nijpels G; Heine RJ; 't Hart LM; de Groot PG; Stehouwer CD; Schalkwijk CG
J Clin Endocrinol Metab; 2009 Dec; 94(12):5174-80. PubMed ID: 19890027
[TBL] [Abstract][Full Text] [Related]
10. A419C (E111A) polymorphism of the glyoxalase I gene and vascular complications in chronic hemodialysis patients.
Kalousová M; Germanová A; Jáchymová M; Mestek O; Tesar V; Zima T
Ann N Y Acad Sci; 2008 Apr; 1126():268-71. PubMed ID: 18079478
[TBL] [Abstract][Full Text] [Related]
11. Fructosamine 3-kinase and glyoxalase I polymorphisms and their association with soluble RAGE and adhesion molecules in diabetes.
Škrha J; Muravská A; Flekač M; Horová E; Novák J; Novotný A; Prázný M; Škrha J; Kvasnička J; Landová L; Jáchymová M; Zima T; Kalousová M
Physiol Res; 2014; 63(Suppl 2):S283-91. PubMed ID: 24908234
[TBL] [Abstract][Full Text] [Related]
12. Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor.
Rzepka R; Dołęgowska B; Sałata D; Rajewska A; Budkowska M; Domański L; Kwiatkowski S; Mikołajek-Bedner W; Torbé A
BMC Pregnancy Childbirth; 2015 Jun; 15():134. PubMed ID: 26059227
[TBL] [Abstract][Full Text] [Related]
13. Glyoxalase I Glu111Ala polymorphism in patients with breast cancer.
Germanová A; Germanová A; Tesarová P; Jáchymová M; Zvára K; Zima T; Kalousová M
Cancer Invest; 2009 Jul; 27(6):655-60. PubMed ID: 19452310
[TBL] [Abstract][Full Text] [Related]
14. Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients.
Kalousová M; Jáchymová M; Germanová A; Kubena AA; Tesar V; Zima T
Kidney Blood Press Res; 2010; 33(1):30-6. PubMed ID: 20185929
[TBL] [Abstract][Full Text] [Related]
15. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
[TBL] [Abstract][Full Text] [Related]
16. Association of polymorphisms of the receptor for advanced glycation end products gene and susceptibility to sporadic abdominal aortic aneurysm.
Yao Y; Zhuang J; Li Y; Jing B; Li H; Li J; Shao C; Li K; Wang H
Biomed Res Int; 2015; 2015():394126. PubMed ID: 25789318
[TBL] [Abstract][Full Text] [Related]
17. Receptor for advanced glycation end products (RAGE) gene polymorphism and cardiovascular disease in end-stage renal disease patients.
Buraczynska M; Zaluska W; Buraczynska K; Markowska-Gosik D; Ksiazek A
Hum Immunol; 2015 Nov; 76(11):843-8. PubMed ID: 26429324
[TBL] [Abstract][Full Text] [Related]
18. Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients.
Bansal S; Chawla D; Banerjee BD; Madhu SV; Tripathi AK
Gene; 2013 Sep; 526(2):325-30. PubMed ID: 23721855
[TBL] [Abstract][Full Text] [Related]
19. The regulation of soluble receptor for AGEs contributes to carbonyl stress in schizophrenia.
Miyashita M; Watanabe T; Ichikawa T; Toriumi K; Horiuchi Y; Kobori A; Kushima I; Hashimoto R; Fukumoto M; Koike S; Ujike H; Arinami T; Tatebayashi Y; Kasai K; Takeda M; Ozaki N; Okazaki Y; Yoshikawa T; Amano N; Washizuka S; Yamamoto H; Miyata T; Itokawa M; Yamamoto Y; Arai M
Biochem Biophys Res Commun; 2016 Oct; 479(3):447-452. PubMed ID: 27641663
[TBL] [Abstract][Full Text] [Related]
20. Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.
Tesarová P; Kalousová M; Jáchymová M; Mestek O; Petruzelka L; Zima T
Cancer Invest; 2007 Dec; 25(8):720-5. PubMed ID: 18058469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
